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1. Introduction
 
   Colorimetry is concerned about the measurement of 
the intensity of electromagnetic radiation in the visible 
spectrum transmitted through a solution or transparent 
solid. Passing of electromagnetic radiation through object 
or solution leads to absorption of certain wavelength, 
leaving unabsorbed wavelength to be transmitted or 
reflected. This observed as color which is complementary 
to absorbed color[1]. 
   Bougainvillea spectabilis (B. spectabilis) belonging to 
Nyctaginaceae family is a popular ornamental plant, 
commonly known as “paper flower” due to the bracts 
are thin and papery. B. spectabilis is used in several 
countries to prepare extracts with antibacterial activity[2-4]. 
Its aqueous and methanolic extracts show good oral 
glucose tolerance and significantly reduce the intestinal 
glucosidase activity. Study on leaves revealed its potential 
as anti-inflammatory, anti-diabetic, anti-fertility, 
antiviral, antibacterial and so on[5-11].
   Lidocaine [2-(diethylamino)-N-(2,6-dimethylphenyl)
acetamide] is a first amino amide-type local anaesthetic, 
white or slightly yellowish, crystalline powder, having 
molecular formula C14H22N2O and molecular weight 234.34 g/
mol (Figure 1). Lidocaine is used topically to relieve itching, 
burning and pain from skin inflammations, injected as a 
dental anesthetic or as a local anesthetic for minor surgery. It 
acts by blocking the fast voltage gated sodium (Na+) channels 
ARTICLE INFO                           ABSTRACT
Article history:
Received 27 Apr 2014
Received in revised form 15 May 2014
Accepted 20 Jun 2014
Available online 1 Sep 2014
Keywords:
Colorimetric method
Bougainvillea spectabilis
Lidocaine
Ranolazine
Validation
Objective: To develop and validate a simple, accurate and precise colorimetric method using 
Bougainvillea spectabilis (B. spectabilis) bract color previously not exploited for estimation of 
amide group containing drugs i.e. lidocaine and ranolazine in pharmaceutical formulations. 
Methods: Methanolic extract of B. spectabilis was prepared and evaluated for stability of its 
color at different pH and temperature for a period of 3 weeks. The accuracy and reliability of 
the proposed method was ascertained by evaluating various validation parameters like linearity, 
precision, limit of detection, limit of quantitation and specificity according to International 
Conference on Harmonization guidelines. About 0.5% of B. spectabilis bract color was added to 
the working standard solutions of the drugs separately and after formation of color complex, and 
absorbances were noted at 418 nm. 
Results: For color complexes of lidocaine and ranolazine, linearity was found to be in the range 
of 4 to 24 and 5 to 25 µg/mL respectively. The % relative standard deviation was found to be within 
specification limits. Presence of lone pair of electron on nitrogen of amide group of both drugs 
shows basic nature, contributed in formation of color complex between amide and the color 
pigment obtained from B. spectabilis bracts. 
Conclusions: It can be concluded that the method is simple, accurate, economic, and rapid 
hence can be employed for routine analysis.
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in the neuronal cell membranes that are responsible for 
signal propagation and stabilizes the membrane[12,13].
   Ranolazine [(RS)-N-(2,6-dimethylphenyl)-2-[4-[2-
hydroxy-3-(2-methoxyphenoxy)-propyl] piperazin-1-yl]
acetamide] is an antianginal medication, white or slightly 
yellow, crystalline powder having molecular formula 
C24H33N3O4 and molecular weight 427.537 g/mol (Figure 
1). Ranolazine affects the sodium-dependent calcium 
channels during myocardial ischemia in rabbits and alters 
the transcellular late sodium current. It is useful in the 
treatment of neuropathic pain[14,15].
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Figure 1. Structure of bougainvillein-V (I), lidocaine (II) and ranolazine (III).
   Literature survey reveals that previously work has been 
carried out on estimation of lidocaine either single or in 
combination using UV spectrophotometer[16-18]. Similar type 
of work has also been reported for estimation of ranolazine 
in bulk and tablet dosage form[19,20]. Colorimetric method for 
estimation of both lidocaine and ranolazine using synthetic 
chemicals has been already reported[21,22]. However, 
no attempt has been previously made for colorimetric 
estimation of aforesaid drugs using a natural color pigment. 
So in present work, colorimetric method using extract of B. 
spectabilis bracts was developed for estimation of lidocaine 
and ranolazine based on principle that the amide group due 
to presence of lone pair of electron on nitrogen is going to 
show basic nature which contributes in formation of color 
complex between amide and the color pigment obtained 
from B. spectabilis bracts.
2. Materials and methods
2.1. Plant material
   B. spectabilis bracts were collected from local area (NH4 
highway between Kolhapur and Peth Vadgaon) during the 
flowering season in the month of April to July. The collected 
material was air dried and packed in airtight bags. 
Identification and authentication of plant was done with the 
help of herbarium sheet by Dr. M. Y. Cholekar-Bachulkar, 
Principal, Shri Vijaysinha Yadav Arts and Science College, 
Peth Vadgaon. Further, the herbarium sheet was submitted 
to the Department of Pharmacognosy, Bharati Vidyapeeth 
College of Pharmacy, Kolhapur.
2.2. Chemical
   Lidocaine and ranolazine were procured from 
pharmaceutical companies. Sodium hydroxide, hydrochloric 
acid, ascorbic acid, methanol and other chemical used were 
of analytical grade. Further dilutions were made as per the 
requirement.
2.3. Extraction
   The extracts were obtained by immersing fresh bracts, 
dried bracts and dried bracts powder of B. spectabilis in 1% 
methanolic HCl for 24 h at room temperature. The extract 
was further concentrated under reduced pressure. To the 
concentrated solution, a mixture of diethyl ether and light 
petrol in 2:1 ratio was added when the colouring matter 
separates. The supernatant liquid was decanted after a 
couple of hours and lastly the deep blue-red coloured 
viscous residue was dried in a vacuum dessicator over 
anhydrous calcium chloride.
2.4. Spectrophotometric analysis of extract solution
   A Jasco spectrophotometer (model: UV-630) was used 
to measure the λmax and absorbance of extracts of B. 
spectabilis bracts solutions at pH values of 3, 5 and 8. For 
this sample, 0.06 g each of various extracts of B. spectabilis 
bracts were dissolved in 10 mL of methanol and pH were 
adjusted using 0.1 mol/L HCl and NaOH. The λmax and 
absorbances of the solutions were measured using the 
spectrophotometer in the visible light spectra (400-800 nm) 
(Figure 2). Values of λmax and absorbance at different pH 
are reported in Table 1.
Figure 2. UV overlain spectra of B. spectabilis colour at different pH solution.
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Table 1 
Absorbance and λmax of 0.12% (w/v) solutions of B. spectabilis bracts colour at 
different pH values.
pH λ (nm) Absorbance
3 516.0依0.2 0.290依0.032
5 516.2依0.2 0.420依0.050
8 515.5依0.3 0.440依0.100
Values are expressed as mean依SD, n=3.
2.5. Stability study of B. spectabilis bracts colour
   Reversibility of the colour change was also tested for 
this natural colour. The extract was subjected to various 
treatments including thermal treatment, pH, antioxidant 
additives and light exposure. Colour changes of the 
treated samples were monitored from Week 0 to 3 with a 
UV-visible spectrophotometer. The stability study of B. 
spectabilis bracts colour was carried out by considering 
the following factors.
2.5.1. Additional of antioxidant
   Ascorbic acid of various concentrations, 0.1% (w/v), 
0.5% (w/v) and 1.0% (w/v) was added into the extracts 
separately. Extracts along with ascorbic acid were then 
subjected to pH adjustment. Control was prepared without 
addition of ascorbic acid.
2.5.2. pH treatment
   Samples added with different percentages of ascorbic 
acid were subjected to pH adjustment using 1 mol/L HCl 
or 1 mol/L NaOH. Each set of samples in section was 
adjusted to pH 3.0, pH 5.0 (original pH of B. spectabilis 
bracts) and pH 7.0 respectively. These samples were 
further treated at different temperature.
2.5.3. Heat treatment
   Each set of the sample was finally kept at 4 °C, 25 °C in 
dark and 25 °C with light exposure.
2.5.4. Spectrophotometric analysis 
   Colour changes of the treated samples were monitored 
weekly at 516 nm with a UV-visible spectrophotometer 
from Week 0 to 3.
2.6. Colorimetric estimation of lidocaine and ranolazine 
formulation
2.6.1. Selection of drug
   Phytochemical investigation of extract of B. spectabilis 
bract shows presence of betalain group of compounds 
which have polyphenolic nature similar to synthetic dyes 
like methyl orange, bromocresol green, etc. The synthetic 
dyes generally show reactivity with amide linkage 
whenever colorimetric method has to be developed. 
As lidocaine and ranolazine contain amide linkage, 
the selection of drug was done for colorimetric method 
development.
2.6.2. Preparation of standard stock solutions
2.6.2.1. Lidocaine
   Standard stock solution of lidocaine was prepared by 
dissolving 50 mg of lidocaine in few mL of methanol by 
sonication and the final volume was made up to 100 mL 
using methanol to get a stock solution having concentration 
500 µg/mL.
2.6.2.2. Ranolazine
   Standard stock solution of ranolazine was prepared by 
dissolving 20 mg of ranolazine in few mL of methanol by 
sonication and the final volume was made up to 100 mL with 
methanol to get a stock solution having concentration 200 µg/
mL.
2.6.3. Preparation of standard working solutions
2.6.3.1. Lidocaine
   A volume of 0.4 mL of stock solution was pipetted out in 
10 mL graduated volumetric flask. Volume was made up to 
10 mL with methanol to give standard working solution of 
20 µg/mL of lidocaine.
2.6.3.2. Ranolazine
   A volume of 1 mL of stock solution was pipetted out in 
10 mL graduated volumetric flask. Volume was made up to 
10 mL with methanol to give standard working solution of 
20 µg/mL of ranolazine.
2.6.4. Optimization of reagents and reaction condition
2.6.4.1. Lidocaine
   Temperature of reaction, quantity, concentration and 
sequence of addition of reagents were optimized after several 
experimental trails. Using extract, solutions of different 
concentration like 0.5%, 1%, 1.5% and 2% were prepared 
in methanol. About 1 mL of standard working solution of 
lidocaine having concentration 20 µg/mL was pipetted out in 
different 10 mL graduated volumetric flasks. To this 1 mL of 
extract, solution having different concentrations was added. 
All the solutions were screened at identified λmax (418 nm). 
It was found that 0.5% solution of extract gives excellent 
color complex.
   The optimization of volume of 0.5% solution was the next 
step. About 0.48 mL volume of 0.5% extract of B. spectabilis 
bract solution was found to be optimum for completion 
of reaction. The intensity of the colour formed, reached 
maximum in 10 min after mixing the reagent at room 
temperature and was stable up to 2 h.
2.6.4.2. Ranolazine
   Using extract, solutions of different concentration like 0.5%, 
1%, 1.5% and 2% were prepared in methanol. Stock solution of 
1 000 µg/mL of ranolazine was prepared. From this, 0.1 mL was 
pipetted out in 10 mL volumetric flask. To this 1 mL of above 
extract, solution with different concentration was added. 
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Identification of λmax for developed complex was carried 
out, which was found to be 418 nm.
2.6.5. Procedure for plotting calibration curve
2.6.5.1. Lidocaine
   Serial volumes of standard working solution were 
pipetted out into a series of 10 mL volumetric flasks. To 
each volumetric flask, 1 mL of 0.5% extract solution of B. 
spectabilis bract was added and the volume was then made 
up to 10 mL with methanol to get final concentrations of 
4 to 24 µg/mL. Flasks were kept aside for 5 to 10 min for 
completion of formation of reaction complex in dark. The 
absorbance of the red colored complex was measured at 
418 nm against reagent blank.
2.6.5.2. Ranolazine
   Appropriate aliquots of standard drug solution were 
taken into a series of 10 mL volumetric flasks. To each 
volumetric flask, freshly prepared 0.5% solution of extract 
of B. spectabilis bracts was added and the volume was then 
made up to 10 mL with methanol to get final concentrations 
of 5 to 25 µg/mL and kept aside for 10 min for completion 
of formation of color complex. The absorbance of the pale 
yellow colored complex was measured at 418 nm against 
reagent blank.
2.6.6. Spectrophotometric analysis of drug-extract complexes
   A Jasco spectrophotometer (model: UV-630) was used to 
measure the λmax and absorbance of lidocaine-extract color 
complex and ranolazine-extract color complex.
2.6.7. Fourier transform infrared spectroscopy (FTIR) study
   Study of possible interaction between B. spectabilis extract 
and drug i.e. lidocaine and ranolazine has also been carried 
out using an infrared spectrophotometer (Jasco-V-730 
model).
2.7. Method validation
2.7.1. Analysis of formulation
   An accurately measured volume equivalent to 10 mg of 
lidocaine was dissolved in 10 mL of methanol by sonication. 
The solution was then filtered through Whatman filter paper 
No. 41. Appropriate aliquots within the Beer’s law limit 
were analyzed by the proposed method using the procedure 
described earlier. The concentration of lidocaine present in 
the sample solution was calculated by using the formula:
Absorbances=A+B伊C 
   Where, A=-0.005 32, B=0.000 327 8 and C=concentration of 
lidocaine.
2.7.2. Accuracy
   Accuracy of the proposed method was determined using 
recovery studies. The recovery studies were conducted by 
adding different amounts (80%, 100% and 120%) of the pure 
drug to the pre-analysed formulation. The solutions were 
prepared in triplicates and the % recovery was calculated.
2.7.3. Precision
   Precision studies were carried out to determine the 
reproducibility of the proposed method. Repeatability was 
determined by preparing nine replicates of three different 
concentrations of the sample and the absorbance was 
measured. For lidocaine sample, concentration was 4, 12 
and 20 µg/mL whilst for ranolazine it was 5, 10 and 25 µg/mL. 
Intraday precision study was conducted by preparing drug 
solution of aforesaid concentration and analyzing it at three 
different times in a day. To determine interday precision, 
the same procedure was followed for three different days. 
Precision should be investigated using homogeneous, 
authentic samples. However, if it is not possible to obtain 
a homogeneous sample, it may be investigated using 
artificially prepared samples or a sample solution. The 
precision of an analytical procedure is usually expressed as 
the variance, standard deviation or coefficient of variation of 
a series of measurements. 
2.7.4. Specificity
   Analytical techniques that can measure the analyte 
response in the presence of all potential sample components 
should be used for specificity validation.
2.7.5. Limit of detection (LOD)
   LOD is the lowest amount of analyte in the sample that 
can be detected. LOD may also be calculated based on the 
standard deviation of the response (SD) and the slope of 
the calibration curve (S) at levels approximating the LOD 
according to the formula:
LOD=3.3(SD/S)
2.7.6. Limit of quantitation (LOQ)
   LOQ is the least possible quantity of analyte in the sample 
that can be quantitatively determined by suitable precision 
and accuracy. The calculation method is again based on the 
standard deviation of the response (SD) and the slope of the 
calibration curve (S) according to the formula:
LOQ=10(SD/S)
2.7.7. Linearity
   The linearity of the analytical method was its capability 
to bring forth test results which are directly proportional 
to analyte concentration in samples within a given range. 
It may be demonstrated directly on the test substance 
(by dilution of a standard stock solution) or by separately 
weighing synthetic mixtures of the test product components. 
The response for the complex was strictly linear in the 
investigated concentration range.
3. Results 
   Extract was successfully isolated from B. spectabilis 
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bracts and percentage yield was found to be in the range 
of 18.3%-22.5% in methanol.
3.1. Stability study of B. spectabilis bracts colour
3.1.1. Additional antioxidant
   Addition of 0.1% ascorbic acid to B. spectabilis bracts 
colour managed to preserve the colour in all dark storage 
conditions. Unfortunately, 0.1% ascorbic acid was not 
enough to stop colour degradation in sample exposed 
to light. Contrast to this, addition of 1.0% ascorbic acid 
managed to preserve the colour of the pigment, though 
the extract was exposed to light. Results are shown in 
Tables 2 and 3.
3.1.2. pH treatment
   Sample at pH 7, stored in the dark at 4 °C showed 
approximately 25% degradation from the initial reading 
after 3 weeks. In contrast, sample at pH 3 managed to 
maintain 80% of the colour at the end of Week 3. The 
results indicated that betacyanin seems to be in favor of 
acidic pH region (Tables 2 and 3). 
Table 3
Effect of pH, temperature and antioxidant on the degradation of extract of B. 
spectabilis colour at 4 °C.
pH Concentration of 
ascorbic acid (%)
4 °C (dark)
Week 0 Week 1 Week 2 Week 3
3 0.1 0.3依0.1 11.0依1.2 16.3依0.6 20.2依0.8
0.5 0.2依0.3 10.9依1.5 14.7依0.3 19.6依1.1
1.0 0.3依0.2   9.5依1.4 15.8依0.2 19.2依2.3
5 0.1 0.4依0.9 12.0依0.5 17.1依0.7 22.1依1.4
0.5 0.5依0.4 11.8依0.6 16.1依1.0 21.6依0.6
1.0 0.4依0.2 10.3依0.3 16.5依1.0 21.1依0.4
7 0.1 0.6依0.4 13.5依0.5 19.8依0.4 25.0依0.2
0.5 0.5依0.6 13.2依0.4 19.3依0.6 24.7依0.6
1.0 0.4依0.5 12.6依1.0 18.9依0.3 21.7依2.1
Data are expressed as mean依SD, n=3. Degradation (%)=(original 
concentration−determined concentration)×100.
3.1.3. Heat treatment
   Results revealed light as the major factor of betalain 
pigment degradation. Refrigeration storage (4 °C) condition 
without light exposure managed to preserve the colour 
up to 3 weeks than storage at 25 °C with exposure to light 
(Tables 2 and 3).
3.2. Optimization of reagents and reaction condition
   For lidocaine, the method employs 0.5% solution of 
B. spectabilis bracts prepared by making use of freshly 
prepared extract. The absorption peak of complex was 
located at 418 nm. Temperature of reaction, quantity, 
concentration and sequence of addition of reagents were 
optimized after several experimental trials. For lidocaine, 
the optimum quantity and concentration of B. spectabilis 
bracts dried extract solution was found to be 0.48 mL of 
0.5% solution. The concentration of lidocaine over a range 
of 4 to 24 µg/mL was found to obey Beer’s law (Table 4). 
Table 4
Absorbance values for calibration curve of lidocaine colour complex and 
ranolazine color complex.
Complex Concentration (µg/mL) Absorbance
Lidocaine  4 0.017
 8 0.042
12 0.065
16 0.090
20 0.114
24 0.142
Ranolazine  5 0.053
10 0.069
15 0.082
20 0.095
25 0.111
- -
 
   For ranolazine, the optimum quantity and concentration 
of B. spectabilis extract solution was found to be 0.48 mL 
of 0.5% solution. The concentration of ranolazine over a 
range of 1-25 µg/mL was found to obey Beer’s law in the 
Table 2
Effect of pH, temperature and antioxidant on the degradation of extract of B. spectabilis colour at 25 °C.
pH Concentration of 
ascorbic acid (%)
25 °C (light) 25 °C (dark)
Weak 0 Weak 1 Weak 2 Weak 3 Weak 0 Weak 1 Weak 2 Weak 3
3 0.1 0.7依0.3 7.0依0.1 45.9依0.4 60.8依0.6 0.3依0.5 6.8依0.5 43.6依1.4 60.5依0.6
0.5 0.7依0.5 8.5依1.2 40.4依0.2 68.2依0.4 0.2依0.4 6.6依1.4 38.7依0.7 56.7依1.3
1.0 0.5依0.3 8.7依0.3 32.5依1.2 66.9依0.5 0.3依0.2 6.2依0.3 27.5依1.0 50.3依1.1 
5 0.1 0.6依0.4       10.0依1.6 48.1依0.3 72.7依0.5 0.2依0.8 9.7依0.3 36.4依0.5 64.3依0.5
0.5 0.4依0.5       10.5依0.5 39.3依0.5 70.3依1.5 0.4依0.6       10.0依0.4 30.5依0.8 61.4依0.8
1.0 0.4依0.9 9.3依1.0 30.0依1.0 68.4依0.3 0.3依0.1 9.1依1.1 22.7依1.0 59.1依0.2
7 0.1 0.7依0.4       25.0依0.4 54.6依0.9 80.1依0.6 0.6依0.3       19.4依1.2 48.0依0.4 48.0依0.4
0.5 0.6依0.3       22.4依2.5 43.3依0.6 74.6依0.8 0.3依0.4 19.0依0.9 36.2依0.7 65.8依0.9
1.0 0.5依0.2       21.6依0.3 35.5依2.5 71.1依1.4 0.1依0.8 17.3依0.6 30.6依0.3 66.0依1.3
Data are expressed as mean依SD, n=3. Degradation (%)=(original concentration−determined concentration)×100.
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stated range employed for analysis (Table 4). The correlation 
coefficient value for this curve was 0.998. The intensity of 
the colour formed, reached maximum in 1 min after mixing 
the reagent at room temperature and was stable up to 1 h. 
The results showed that optimal condition for the reaction 
of B. spectabilis bracts extract solution with ranolazine was 
in an alkaline medium. General mechanism of complex 
formation is reported in Figure 3.
Figure 3. Possible mechanism action of colorimetric reaction.
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n-π  Complex
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3.3. Spectrophotometric analysis of drug-extract complexes
   UV spectra of B. spectabilis color, lidocaine and 
lidocaine-color complex has been reported in Figure 4. 
While UV spectra of B. spectabilis color, ranolazine and 
ranolazine-color complex has been reported in Figure 5. UV 
overlain spectra of lidocaine color complex and ranolazine-
color complex has shown in Figure 6 A and B respectively.
Figure 4. UV spectra of B. spectabilis extract (A), lidocaine (B) and lidocaine–
color complex (C).
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Figure 5. UV spectra of B. spectabilis extract (A), ranolazine (B) and 
ranolazine–color complex (C) .
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Figure 6. UV overlain spectra of lidocaine-colour complex (A) and 
ranolazine-colour complex (B) .
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3.4. FTIR study
   FTIR study of pure drugs (lidocaine and ranolazine), 
extract of B. spectabilis and complex of extract and drug 
indicated there were no incompatibilities between extract 
and drugs. B. spectabilis color showed major peak was at 
3 375.89 wavenumber cm-1 which corresponds to phenols, 
-OH stretching. Even as peak was found to be retained 
in B. spectabilis color-lidocaine complex was at 3 322.17 
wavenumber cm-1 which also corresponds to phenols, -OH 
stretching. While in case of B. spectabilis color-ranolazine 
complex peak was at 3 222.15 wavenumber cm-1 and 
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corresponded the same. So the major peak has found be 
retained both in color and complexes (Figures 7 and 8).  
Figure 7. FTIR spectra of B. spectabilis extract (A), lidocaine (B) and 
lidocaine-colour complex (C). 
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Figure 8. FTIR spectra of B. spectabilis extract (A), ranolazine (B) and 
ranolazine-colour complex (C) .
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3.5. Method validation
3.5.1. Accuracy
   The results indicated excellent recoveries ranging from 
98.33% to 99.60% and 98.33% to 99.50% for lidocaine and 
ranolazine respectively and reliability of the method 
(Table 5). Recoveries obtained for the drug did not 
differ significantly from 100% showing that there was 
no interference from common excipients used in the 
formulation and thus indicating accuracy and reliability of 
the method.
Table 5
Results of accuracy.
Level Concentration 
added (mg)
Concentration 
found (mg)
% Recovery % RSD
Lidocaine  80% 34.16 34.02 99.60 0.253
100% 42.70 41.83 97.95 0.266
120% 51.24 50.98 98.33 0.592
Ranolazine  80%  8.00  7.87 98.33 0.898
100% 10.00  9.82 98.73 1.386
120% 12.00 11.94 99.50 0.971
RSD: relative standard deviation.
3.5.2. Precision
   Intraday and interday precision was found to be 
approximately 99% for both lidocaine and ranolazine. 
Results of repeatability have reported as % relative standard 
deviation in Table 6.
Table 6 
Results of repeatability (intraday and interday).
Analyte Concentration
(µg/mL)
Concentration estimated (%)
Lidocaine Intraday  4 99.410依0.102
12 99.720依0.160
20 99.010依0.225
Interday  4 96.750依0.212
12 99.080依0.110
20 99.410依0.189
Ranolazine Intraday  5 98.730依0.060
10 99.590依0.062
25 99.620依0.086
Interday  5 98.600依0.014
10 99.480依0.066
25 99.440依0.040
Data are expressed as mean依SD, n=9.
3.5.3. LOD
   LOD was found to be 0.088 and 0.26 µg/mL for lidocaine 
and ranolazine respectively.
3.5.4. LOQ
   LOQ was found to be 0.266 and 0.80 µg/mL lidocaine and 
ranolazine respectively.
4. Discussion
   Formation of color complex between drugs and extract is 
contributed to the keto-enol tautomerism. Electrons on the 
phenolics oxygen get simply delocalized in aromatic ring, 
making it acidic due to easy removal of proton (H+). While 
amide due to presence of lone pair of electron on nitrogen is 
going to show basic nature which contributes in formation 
of color complex between amide and the color pigment 
obtained from B. spectabilis. Study revealed that increased 
concentration of ascorbic acid directly contributed in 
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stability of color. Extract mainly contains betalains, stable 
at acidic pH so it is essential to store up this extract at 
acidic pH to maintain its activity.
   Betalains are the compound mainly responsible for 
color of B. spectabilis bract which mainly contains 
bougainvillein-V. B. spectabilis bracts color was found to 
be less stable at 25 °C exposed to light and at pH 7. While, 
refrigeration storage (4 °C) condition without light exposure 
managed to preserve the color up to 3 weeks than storage 
at 25 °C with exposure to light. The proposed method for 
colorimetric estimation of lidocaine and ranolazine is 
accurate, precise, economical and convenient, yielding 
reproducible results. Moreover, the method is economic, 
simple and rapid, hence can be employed for routine 
analysis in quality control laboratories as it is specific 
without interference of excipients. If the B. spectabilis 
bract extact is stored properly, this could be useful in 
colorimetric estimation of aforesaid amide containing drugs. 
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